Demand assessment and price-elasticity estimation of quality-improved primary health care in Palestine: A contribution from the contingent valuation method

Health Economics

Volumn 16, Issue 10, 2007, Pages 1051-1068

  Mataria, Awad ^a,c   Luchini, Stéphane ^c   Daoud, Yousef ^c   Moatti, Jean Paul ^a,b,c,d,e  

^a INSERM   (France)

^b Reg Ctr Dis Ctrl South E France   (France)

^c BIRZEIT UNIVERSITY   (Palestine)

^d Centre National de la Recherche Scientifique   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cost sharing; Demand assessment; Price elasticity; Weibull distribution; Willingness to pay

Indexed keywords

ARTICLE; CONSULTATION; CONTINGENT VALUATION; CONTROLLED STUDY; ECONOMIC EVALUATION; FEE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INCOME; INTERVIEW; MAJOR CLINICAL STUDY; PALESTINE; PATIENT ATTITUDE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROBABILITY; RANDOM SAMPLE; STATISTICAL MODEL; SURVIVAL;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE EAST; MODELS, ECONOMETRIC; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; SOCIOECONOMIC FACTORS;

EID: 35148881607     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1216     Document Type: Article

References (58)

1. Abel-Smith B, Rawal P. 1992. Can the poor afford free health service? A case study of Tanzania. Health Policy and Planning 7: 329-341.
2. Akaike H. 1981. Likelihood of a Model and Information Criteria. Journal of Economics 16: 3-14.
3. Akin JS, Hutchinson P. 1999. Health care financing choice and the phenomenon of bypassing. Health Policy and Planning 14: 135-151.
4. Alderman H, Lavy V. 1996. Household responses to public health services: cost and quality tradeoffs. World Bank Research Observer 11: 3-22.
5. Arrow K, Solow R, Portney PR, Leamer EE, Radner R, Schuman H. 1993. Report of the NOAA Panel of Contingent Valuation. Federal Register 58: 4601-4614.
6. Asenso-Okyere WK, Osei-Akoto I, Anum A, Appiah EN. 1997. Willingness to pay for health insurance in a developing economy. A pilot study of the informal sector of Ghana using contingent valuation. Health Policy 42: 223-237.
7. Barlow R, Diop F. 1995. Increasing the utilization of cost-effective health services through changes in demand. Health Policy and Planning 10: 284-295.
8. Bratt JH, Weaver MA, Foreit J, De Vargas T, Janowitz B. 2002. The impact of price changes on demand for family planning and reproductive health services in Ecuador. Health Policy and Planning 17: 281-287.
9. Chernichovsky D, Meesook OA. 1986. Utilization of health services in Indonesia. Social Science and Medicine 23: 611-620.
10. Cissé B, Luchini S, Moatti JP. 2004. Recouvrement des coûts et demande de soins dans les Pays en Développement. Revice Franchise d' Economic XVIII: 111-140.
11. Cummings RG, Harrison GW, Rutstrom EE. 1995. Homegrown values and hypothetical surveys: is the dichotomous choice approach incentive-compatible? American Economic Review 85: 260-266.
12. Donaldson C, Thomas R, Torgerson DG. 1997. Validity of open-ended and payment scale approaches to eliciting willingness to pay. Applied Economics 29: 79-84.
13. Dumoulin J. 1993. Le paiement des soins par les usagers dans les pays d'Afrique sub-saharienne: rationalité économique et autres questions subséquentes. Sciences Sociales et Sante 11: 81-119.
14. Ellis RP, McInnes DK, Stephenson EH. 1994. In-patient and out-patient health care demand in Cairo, Egypt. Health Economics 3: 183-200.
15. Foreit JR, Foreit KGF. 2003. The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries. Health Policy 63: 37-47.
16. Gertler P, Locay L, Sanderson W. 1987. Are user fees regressive? The welfare implications of health care financing proposals in Peru. Journal of Economics 36: 67-88.
17. Gertler P, Molyneaux J. 1997. Experimental Evidence on the Effect of Raising User Fees for Publicly Delivered Health Care Services: Utilization, Health Outcomes, and Private Provider Response. Rand Corp: Santa Monica, CA.
18. Gertler P, Hammer JS. 1997. Strategies for Pricing Publicly Provided Health Services. University of California at Berkeley and The World Bank, 1-37.
19. Gilson L. 1997. The lessons of user fee experience in Africa. Health Policy and Planning 12: 273-285.
20. Gilson L, McIntyre D. 2005. Removing user fees for primary care in Africa: the need for careful action. British Medical Journal 331: 762-765.
21. Greene W. 2000. Econometric Analysis. Prentice-Hall Inc: New Jersey, 1004.
22. Griffin DC. 1992. Welfare gains from user charges for government health services. Health Policy and Planning 7: 177-180.
23. Gyldmark M, Morrison GC. 2001. Demand for health care in Denmark: results of a national sample survey using contingent valuation. Social Science and Medicine 53: 1023-1036.
24. Hassan E, El Nahal N, El-Hussein M. 1994. Acceptability of the once-a-month injectable contraceptives cyclofem and mesigyna in Egypt. Contraception 49: 469-488.
25. Johannesson M, Jonsson B. 1991. Economic evaluation in health care: is there a role for cost-benefit analysis? Health Policy and planning 17: 1-23.
26. Kemp MA, Maxwell C. 1993. Exploring a budget context for contingent valuation estimates. In Contingent Valuation: A Critical Assessment, Hausman JAE (ed.). North Holland Press: Amsterdam.
27. Kennedy P. 1998. A Guide to Econometrics. (4th edn). MIT Press: Massachusetts, 468.
28. Kiefer NM. 1988. Economic duration data and hazard functions. Journal of Economic Literature 26: 646-679.
29. Klose T. 1999. The contingent valuation method in health care. Health Policy 47: 97-123.
30. Kriström B. 1990. A non-parametric approach to the estimation of welfare measures in discrete response valuation. Land Economics 66: 135-139.
31. Leighton C. 1995. Overview: health financing reforms in Africa. Health Policy and Planning 10: 213-222.
32. Liljas B, Blumenschein K. 2000. On hypothetical bias and calibration in cost-benefit studies. Health Policy 52: 53-70.
33. Litvack JI, Bodart C. 1993. User fees plus quality equals improved access to health care: results of a field experiment in Cameroon. Social Science and Medicine 37: 369-383.
34. Mariko M. 2003. Quality of care and the demand for health services in Bamako, Mali: the specific roles of structural, process, and outcome components. Social Science and Medicine 56: 1183-1196.
35. Mataria A, Donaldson C, Luchini S, Moatti JP. 2004. A stated preference approach to assessing health care-quality improvements in Palestine: from theoretical validity to policy implications. Journal of Health Economics 23: 1285-1311.
36. McPake B. 1993. User charges for health services in developing countries: a review of the economic literature. Social Science and Medicine 36: 1397-1405.
37. McPake B, Hanson K, et al. 1993. Community finance of health care in Africa: An evaluation of the Bamako Initiative. Social Science and Medicine 36: 1383-1395.
38. Mitchell R, Carson R. 1989. Using Surveys to Value Public Goods: The Contingent Valuation Method. Resources for the Future: Washington DC.
39. MOH-MHIS. 2002. Health status in Palestine: Annual Report 2001. Ministry of Health - Health Management Information System: Ramallah (Occupied Palestinian Territory).
40. Mwabu G, Ainsworth M, Nyamete A. 1993. Quality of medical care and choice of medical treatment in Kenya. Journal of Human Resources 28: 838-862.
41. Newhouse J. 1995. Free for All. Harvard University Press: Cambridge.
42. NSHP. 1999. National Strategic Health Plan (1999-2003). Palestinian National Authority, Palestine.
43. O'Brien B, Gafni A. 1996. When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in health care. Medical Decision Making 16: 288-299.
44. Olsen JA, Donaldson C. 1998. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programs. Social Science and Medicine 46: 1-12.
45. Onwujekwe O, Chima R, Shu E, Nwagbo D, Akpala C, Okonkwo P. 2002. Altruistic willingness to pay in community-based sales of insecticide-treated nets exists in Nigeria. Social Science and Medicine 54: 519-527.
46. Onwujekwe O, Chima R, Shu E, Nwagbo D, Okonkwo P. 2001. Hypothetical and actual willingness to pay for insecticide-treated nets in five Nigerian communities. Tropical Medicine and International Health 6: 545-553.
47. Onwujekwe O, Hanson K, Fox-Rushby J. 2005. Do divergences between stated and actual willingness to pay signify the existence of bias in contingent valuation surveys? Social Science and Medicine 60: 525-536.
48. Population Council. 1998. Price elasticity of demand for reproductive health services at an Ecuadorian private voluntary organization. http://www.popcouncil.org/pdfs/inopal/015.pdf [19 February 2003].
49. Ryan M, Scott DA, Donaldson C. 2004. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods. Journal of Health Economics 23: 237-258.
50. Ryan M, Scott DA, Reeves C et al. 2001. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technology Assessment 5: 1-186.
51. Sauerborn R, Nougtara A, Latimer E. 1994. The elasticity of the demand for health care in Bukina Faso: differences across age and income groups. Health Policy and Planning 9: 185-192.
52. StataCorp. 2001. Stata Statistical Software: Release 7.0. Stata Corporation: College Station, Texas.
53. Stewart JM, O'Shea E, Donaldson C, Shackley P. 2002. Do ordering effects matter in willingness-to-pay studies of health care? Journal of Health Economics 21: 585-599.
54. Varian H. 2000. Introduction à la Microéconomie. Boeck Université: Paris.
55. Waddington CJ, Enyimayew KA. 1990. A price to pay: the impact of user charges in the Volta region of Ghana. International Journal of Health Planning and Management 5: 287-312.
56. Weaver M, Ndamobissi R, Kornfield R et al. Willingness to pay for child survival: results of a national survey in Central African Republic. Social Science and Medicine 43: 985-998.
57. Whittington D, Matsui-Santana O, Freiberger J, Van Houtvin G, Pattanayak S. 2002. Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico. Vaccine 20: 2585-2591.
58. Wouters A. 1995. Improving quality through cost recovery in Niger. Health Policy and Planning 10: 257-270.